Inactivation of the Fanconi anemia group C gene augments interferon-γ- induced apoptotic responses in hematopoietic cells

Blood

Volumn 90, Issue 3, 1997, Pages 974-985

  Rathbun, R Keaney ^b   Faulkner, Gregory R ^b   Ostroski, Marika H ^b   Christianson, Tracy A ^b   Hughes, Grant ^b   Jones, Gary ^b   Cahn, Robert ^b   Maziarz, Richard ^b   Royle, Gordon ^b   Keeble, Winifred ^b   Heinrich, Michael C ^b   Grompe, Markus ^b   Tower, Paula A ^b   Bagby, Grover C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; APOPTOSIS; ARTICLE; FANCONI ANEMIA; GENE LOCUS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030845529     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.974     Document Type: Article

References (67)

1. Schroeder TM, Tilgen D, Kruger J, Vogel F: Formal genetics of Fanconi's anemia. Hum Genet 32:257, 1976
2. Auerbach AD, Allen RG: Leukemia and preleukemia in Fanconi anemia patients: A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 51:1, 1991
3. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD: Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry Study. Blood 84:1650, 1994
4. Liu JM, Buchwald M, Walsh CE, Young NS: Fanconi anemia and novel strategies for therapy, Blood 84:3995, 1994
5. Auerbach AD, Rogatko A, Schroeder-Kurth TM: International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 73:391, 1989
6. Auerbach AD, Adler B, Chaganti RS: Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics 67:128, 1981
7. Strathdee CA, Duncan AM, Buchwald M: Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1:196, 1992
8. Joenje H, Ten Foe JRL, Oostra AB, Van Berkel CGN, Rooimans MA, Schroeder-Kurth T, Wegner RD, Gille JJP, Buchwald M, Arwert F: Classification of Fanconi anemia patients by complementation analysis: Evidence for a fifth genetic subtype. Blood 86:2156, 1995
9. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, van Berkel CGM, Strunk MHP, Gille JJP, Pals G, Kruyt FAE, Pronk JC, Arwert F, Buchwald M, Joenje H: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 14:320, 1996
10. Fanconi anaemia/breast cancer consortium: Positional cloning of the Fanconi anaemia group A gene. Nat Genet 14:324, 1996
11. Gibson RA, Ford D, Jansen S, Savoia A, Havenga C, Milner RD, de Ravel TJ, Cohn RJ, Ball SE, Roberts I: Genetic mapping of the FACC gene and linkage analysis in Fanconi anaemia families. J Med Genet 31:868, 1994
12. Whitney M, Thayer M, Reifsteck C, Oison S, Smith L, Jakobs PM, Leach R, Naylor S, Joenje H, Grompe M: Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet 11:341, 1995
13. Pronk JC, Gibson RA, Savoia A, Wijker M, Morgan NV, Melchionda S, Ford D, Temtamy S, Ortega JJ, Jansen S: Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet 11:338, 1995
14. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992
15. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Erratum: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 358:434, 1992
16. Wevrick R, Clarke CA, Buchwald M: Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet 2:655, 1993
17. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975, 1994
18. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD: The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712, 1994
19. Youssoufian H: Cytoplasmic localization of FAC is essential for the correction of a pre-repair defect in Fanconi anemia group C cells. J Clin Invest 97:2003, 1996
20. Segal GM, Magenis E, Brown M. Keeble W, Smith TD, Heinrich MC, Bagby GC, Magenis RE, Bagby GC Jr: Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 94:846, 1994
21. Walsh CE, Grompe M, Vanin E, Buchwald M, Young NS, Nienhuis AW, Liu JM: A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood 84:453, 1994
22. Whitney MA, Royle G, Low MJ, Kelly MA, Axthelm MK, Reifsteck C, Oison S, Braun RE, Heinrich MC, Rathbun RK, Bagby GC, Grompe M: Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 88:49, 1996
23. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson S, Beyer GS, Huffman R, Rubin BY: The suppressive influences of human tumor necrosis factors on hone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and Interferon gamma. J Immunol 136:4487, 1986
24. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY: Comparative analysis of the influences human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131:1300, 1983
25. Raefsky EL, Platanias LC, Zoumbos NC, Young NS: Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 135:2507, 1985
26. Zoumbos NC. Gascon P, Djeu JY, Young NS: Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82:188, 1985
27. Viale M, Merli A, Bacigalupo A: Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood 78:1268, 1991
28. Nakao S, Yamaguchi M, Shiobara S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T: Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79:2532, 1992
29. Nistico A, Young NS: Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120:463, 1994
30. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 22:1102, 1994
31. Selleri C, Maciejewski JP, Sato T, Young NS: Interferongamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent heinatopoietic inhibition. Blood 87:4149, 1996
32. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP: Interferon-gamma and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165:538, 1995
33. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
34. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokinemediated hematopoietic suppression in vitro. Blood 85:3183, 1995
35. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC: Purification and molecular cloning of the APO-I cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709, 1992
36. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
37. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
38. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation [see comments]. Nature 373:444, 1995
39. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
40. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
41. Owen-Schaub LB, Yonehara S, Crump WL 3d, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
42. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505, 1995
43. Chinnaiyan AM, Tepper CG, Seidin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM: FADD/MORTl is a common mediator of CD95 (Fas/APO-1) and tumor cell necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961, 1996
44. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLlCE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817, 1996
45. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996
46. Tewari M, Dixit VM: Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product, J Biol Chem 270:3255, 1995
47. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and PCC32-like proteases during Fas-medi-ated apoptosis. Nature 380:723, 1996
48. + cells of patients with aplastic anaemia. Br J Haematol 91:245, 1995
49. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980, 1989
50. Kozak SL, Rabat D: Ping-pong amplification of a retroviral vector achieves high-level gene expression: Human growth hormone production. J Virol 64:3500, 1990
51. Segal GM, Smith T, Heinrich MC, Ey FS, Bagby GC: Specific repression of granulocyte-macrophage and granulocyte colony-stimulating factor gene expression in interleukin-1 -stimulated endothelial cells with antisense oligodeoxynucleotides. Blood 80:609, 1992
52. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
53. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
54. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 265:4923, 1990
55. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
56. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR: Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271:28753, 1996
57. Barcena A, Park SW, Banapour B, Muench MO, Mechetner E: Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 88:2013, 1996
58. Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS: Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 96:1085, 1995
59. Ahn NG: The MAP kinase cascade. Discovery of a new signal transduction pathway. Mol Cell Biochem 127-128:201, 1993
60. Shual K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, Darnell JE: Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580, 1993
61. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415, 1994
62. Kim U, Maniatis T: Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway. Science 273:1717, 1996
63. Haspel RL, Salditt-Georgieff M, Darnell JE Jr: The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J 15:6262, 1996
64. Scuderi P, Sterling KE, Raitano AB, Grogan TM, Rippe RA: Recombinant interferon-gamma stimulates the production of human tumor necrosis factor in vitro. J Interferon Res 7:155, 1987
65. Schultz JC, Shahidi NT: Tumor necrosis factor-alpha overproduction in Fanconi's anemia. Am J Hematol 42:196, 1993
66. Alter BP: Fanconi's anemia and malignancies. Am J Hematol 53:99, 1996
67. Alter BP: Leukemia and preleukemia in Fanconi's anemia. Cancer Genet Cytogenet 58:206, 1992